FDA Q&A

• Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

  Q&A with FDA: Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

• Understanding Drug Recalls with Dr. Ileana Elder

  In this episode of the Q&A with FDA podcast, learn about Understanding Drug Recalls with Dr. Ileana Elder in the Office of Compliance.

• Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim

  In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.

• Real-World Data and Evidence Generation with Dr. Hilary Marston

  In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to support the safety and effectiveness of drug products with Dr. Hilary Marston, FDA’s Chief Medical Officer.

• The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad

  Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.

• Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

  Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.

• The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein

  The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein

• Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng

  Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.

• FDA’s Regulation of Dietary Supplements with Dr. Cara Welch

  Listen to our latest podcast series, Q&A with FDA - FDA’s Regulation of Dietary Supplements featuring Dr. Cara Welch.

• A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska

  Listen to our latest podcast series, Q&A with FDA, on A Step Forward in the Treatment of Opioid and Alcohol Dependence featuring Dr. Iilun Murphy and Dr. Marta Sokolowska.

• Navigating the World of Online Pharmacies with CDR Lysette Deshields

  Navigating the World of Online Pharmacies with CDR Lysette Deshields

• CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito

  Listen to our latest podcast series, Q&A with FDA

• FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska

  FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska<br><br>

• Drug Shortages with CDR Emily Thakur

  In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.

• Generics-at-a-Glance with Dr. Sarah Ibrahim

  Generics-at-a-Glance with Dr. Sarah Ibrahim

• Expanded Access with Dr. Jacqueline Corrigan-Curay

  Expanded Access with Dr. Jacqueline Corrigan-Curay

• MedWatch, Your Report Can Make a Difference

  MedWatch, Your Report Can Make a Difference

• FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska

  FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska

• Clinical Trial Basics

  Shedding some light on clinical trials with Dr. Bob Temple

• Conversation on Paxlovid

  In today’s episode, we’ll be discussing Paxlovid, which is now widely available in community pharmacies.